Pharmacotherapy for PTSD

Psychiatric Annals

Volumn 33, Issue 1, 2003, Pages 57-62

  Friedman, Matthew J ^a,b   Donnelly, Craig L ^a   Mellman, Thomas A ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b NATIONAL CENTER FOR PTSD   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENERGIC RECEPTOR BLOCKING AGENT; AMFEBUTAMONE; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; BENZODIAZEPINE; CARBAMAZEPINE; CITALOPRAM; CLONIDINE; FLUOXETINE; FLUVOXAMINE; GABAPENTIN; GUANFACINE; LAMOTRIGINE; MONOAMINE OXIDASE INHIBITOR; NEFAZODONE; NEUROLEPTIC AGENT; OLANZAPINE; PAROXETINE; PRAZOSIN; PROPRANOLOL; RISPERIDONE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT; VALPROIC ACID; VENLAFAXINE;

ANXIETY; ASTHENIA; CHILD CARE; CLINICAL TRIAL; COMORBIDITY; DEPRESSION; DIARRHEA; DRUG APPROVAL; DRUG MARKETING; DRUG MONITORING; DRUG TOLERABILITY; EJACULATION DISORDER; GASTROINTESTINAL DISEASE; HEART MUSCLE CONDUCTION DISTURBANCE; HEMATOLOGIC DISEASE; HUMAN; HYPERTENSIVE CRISIS; IMPOTENCE; INJURY; INSOMNIA; MEDICAL DECISION MAKING; MENTAL PATIENT; METABOLIC DISORDER; NAUSEA; NEUROTOXICITY; ORTHOSTATIC HYPERTENSION; PATIENT MONITORING; POSTTRAUMATIC STRESS DISORDER; PSYCHOPHARMACOTHERAPY; PSYCHOTHERAPY; RESTLESSNESS; REVIEW; SEDATION; SIDE EFFECT; SOMNOLENCE; TREATMENT INDICATION; WEIGHT GAIN; XEROSTOMIA;

EID: 1842455029     PISSN: 00485713     EISSN: None     Source Type: Journal    
DOI: 10.3928/0048-5713-20030101-09     Document Type: Review

References (29)

1. Donnelly CL, Amaya-Jackson L. Post-traumatic stress disorder in children and adolescents: epidemiology, diagnosis and treatment options. Pediatric Drugs. 2002;4:159-170.
2. Friedman MJ, Davidson JRT, Mellman TA, Southwick SM. Guidelines for pharmacotherapy and position paper on practice guidelines. In: Foa EB, Keane TM, Friedman MJ, eds. Effective Treatments for Post-traumatic Stress Disorder: Practice Guidelines from the International Society for Traumatic Stress Studies. New York, NY: Guilford; 2000:84-105.
3. Mellman TA. Rationale and role for medication in the comprehensive treatment of PTSD. In: R Yehuda, ed. Treating Trauma Survivors With PTSD. Washington DC: American Psychiatric Press; 2002:63-74.
4. Bryant RA, Friedman MJ. Medication and non-medication treatments of post-traumatic stress disorder. Curr Opin Psychiatry. 2001;14:119-123.
5. Braun P, Greenberg D, Dasberg H, Lerer B. Core symptoms of posttraumatic stress disorder unimproved by alprazolam treat-ment. J Clin Psychiatry. 1990;51:236-238.
6. Robert R, Blakeney PE, Villarreal C, Rosenberg L, Meyer WJ. Imipramine treatment in pediatric burn patients with symptoms of acute stress disorder: a pilot study. J Am Acad Child Adolesc Psychiatry. 1999;38:873-878.
7. Gelpin E, Bonne O, Peri T, Brandes D, Shalev AY. Treatment of recent trauma survivors with benzodiazepines: a prospective study. J Clin Psychiatry. 1996;57:390-394.
8. Pitman RK, Sanders KM, Zusman RM, et al. Pilot study of secondary prevention of posttraumatic stress disorder with propranolol. Biol Psychiatry. 2002;51:189-192.
9. Blake DD, Weathers FW, Nagy LM, et al. The development of Clinician-Administered PTSD Scale. J Trauma Stress. 1995;8:75-90.
10. Foa EB, Riggs DS, Dancu CV, Rothbaum BO. Reliability and validity of a brief instrument for assessing post-traumatic stress disorder. J Trauma Stress. 1993;6:459-473.
11. Nader KO. Assessing traumatic experiences in children. In: Wilson JP, Keane TM, eds. Assessing Psychological Trauma and PTSD. London: Guilford; 1997:291-348.
12. Keane TM, Weathers FW, Foa EB. Diagnosis and assessment. In: Foa EB, Keane TM, Friedman MJ, eds. Effective Treatments for Post-traumatic Stress Disorder: Practice Guidelines from the International Society for Traumatic Stress Studies. New York: Guilford; 2000:18-36.
13. Wilson JP, Keane TM, eds. Assessing Psychological Trauma and PTSD. London: Guilford Press; 1997.
14. Brady K, Pearlstein T, Asnis GM, et al. Efficacy and safety of sertraline treatment of posttraumatic stress disorder. JAMA. 2000;283:1837-1844.
15. Davidson JRT, Rothbaum BO, van der Kolk BA, et al. Multicenter, double-blind comparison of sertraline and placebo in the treatment of posttraumatic stress disorder. Arch Gen Psychiatry. 2001;58:485-492.
16. Marshall RD, Schneier FR, Knight CBG, et al. An open trial of paroxetine in patients with noncombat-related chronic PTSD. J Clin Psychopharmacol. 1998;18:10-18.
17. Tucker P, Zaninelli R, Yehuda R, Ruggiero L, Dillingham K, Pitts CD. Paroxetine in the treatment of chronic posttraumatic stress disorder: results of a placebo-controlled, flexible-dosage trial. J Clin Psychiatry. 2001;62:860-868.
18. Shalev AY, Friedman MJ, Foa EB, Keane TM. Integration and summary. In: Foa EB, Keane TM, Friedman MJ, eds. Effective Treatments for PTSD: Practice Guidelines from the International Society for Traumatic Stress Studies. New York: Guilford; 2000:359-379.
19. Friedman MJ. Post-traumatic Stress Disorder. Kansas City, MO: Compact Clinicals; 2001.
20. Kessler RC, Sonnega A, Bromet E, et al. Posttraumatic stress disorder in the National Comorbidity Survey. Arch Gen Psychiatry. 1995;52:1048-1060.
21. Davidson JRT, Pearlstein T, Londborg P, et al. Efficacy of sertraline in preventing relapse of posttraumatic stress disorder: results of a 28-week double-blind, placebo-controlled study. Am J Psychiatry. 2002;158:1974-1981.
22. Riddle MA, Kastelic EA, Frosch E. Pediatric psychopharmacology. J Child Psychol Psychiatry. 2001;42:73-90.
23. Deblinger E, Lippman J, Steer I. Sexually abused children suffering posttraumatic stress symptoms: initial treatment outcome findings. Child Maltreatment. 1996;1:310-321.
24. March JS, Amaya-Jackson L, Murray MC, et al. Cognitive-behavioral psychotherapy for children and adolescents with posttraumatic stress disorder after single incident stressor. J Am Acad Child Adolesc Psychiatry. 1998;37:585-593.
25. Seedat S, Lockhat R, Kaminer D, ZunguDirwayi N, Stein DJ. An open trial of citalopram in adolescents with post-traumatic stress disorder. Int Clin Psychopharmacol. 2001;16:21-25.
26. Loof D, Grimley P, Kuller F, Martin A, Shonfield L. Carbemazepine for PTSD [letter]. J Am Acad Child Adolesc Psychiatry. 1995;34:703-704.
27. Harmon RJ, Riggs PD. Clonidine for posttraumatic stress disorder in preschool children. J Am Acad Child Adolesc Psychiatry. 1996;35:1247-1249.
28. Famularo R, Kinscherff R, Fenton T. Propranolol treatment for childhood post-traumatic stress disorder, acute type. Am J Dis Child. 1988;142:1244-1247.
29. Friedman MJ. Future pharmacotherapy for PTSD: prevention and treatment. Psychiatr Clin North Am. 2002;25:1-15.